Episode 92 | Nick Accordino and Will Braeutigam: Deloitte | Taking your Medtech Company Public: SPACs vs. IPOs
- Author
- Project Medtech
- Published
- Mon 09 May 2022
- Episode Link
- https://podcasters.spotify.com/pod/show/projectmedtech/episodes/Episode-92--Nick-Accordino-and-Will-Braeutigam-Deloitte--Taking-your-Medtech-Company-Public-SPACs-vs--IPOs-e1hruvb
- In this episode, Nick Accordino and Will Braeutigam from Deloitte and Duane Mancini discuss discuss SPACs, what are SPACs, why would a company want to go public, the differences in going public through an IPO vs. SPAC, strategic acquisition vs. going public, the myths of going public via a SPAC, preparing your company to go public, and so much more.
- Nick Accordino LinkedIn
- Will Braeutigam LinkedIn
- Deloitte Website
- Project Medtech Website
- Duane Mancini LinkedIn
- Project Medtech LinkedIn
